MeSH tree: D02.455.849.291.850
Cancer cells with a cell nucleus that is easily deformed are more sensitive to drugs that damage DNA. These are the findings of a new study by researchers at Linköping University in Sweden. The results may also explain why ...
Dec 2, 2025
0
28
Imagine a targeted approach to bladder cancer that spares healthy cells while delivering chemotherapy directly to cancerous ones, offering hope for patients with advanced stages of the disease.
Nov 17, 2025
0
13
Currently incurable, peripheral neuropathies are common neurological complications of chemotherapy, causing persistent pain, tingling and burning sensations in the feet and hands, sometimes even after treatment has ended. ...
Oct 30, 2025
0
6
Scientists at Wake Forest University School of Medicine, in collaboration with researchers at Weill Cornell Medicine, have made a breakthrough in understanding why many cancer patients develop nerve damage after chemotherapy. ...
Oct 29, 2025
0
30
Cancer is a challenging enough diagnosis, but many patients are dealt a second blow, even as they heal: "chemo brain."
Oct 13, 2025
0
61
During and after chemotherapy, nearly half of cancer patients endure circadian rhythm disruptions, which worsens treatment side effects. Because the body's primary rhythm pacemaker is in the brain, this suggests that perhaps ...
Sep 8, 2025
1
12
Drug-coated stents and balloons were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in two trials in peripheral artery disease (PAD), according to late-breaking research ...
Sep 1, 2025
0
10
Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit from unpleasant side effects, ...
Aug 28, 2025
0
21
University of Arizona researchers devised a new method to deliver cancer chemotherapy drugs to pancreatic and breast cancer tumors more effectively and with less damage to healthy tissues than standard forms of chemotherapy. ...
Aug 21, 2025
0
26
A new study by University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment.
Jul 9, 2025
0
19
